Tactic Links - Organic Traffic Booster - Home
|
Path: Home > List > Load (peptomyc.com) |
Home | About | List | Rankings | Search | Submit |
| domain | peptomyc.com |
| summary | Peptomycs is a biotech company founded by Dr. Laura Soucek (MYC KOL), Dr. Marie-Eve Beaulieu (protein scientist), and Jesus Martin Garcia (CEO). The founders designed the Omomyc technology, which revealed the therapeutic window of MYC inhibition at research institutes VHIO and ICREA. Peptomycs' leadership team includes CSO Laura Soucek, CDO Marie-Eve Beaulieu, CMO Manuela Niewel, and CFO Jrg Klumbis. The company's Development Advisory Board (DAB) comprises Alain Thibault, Alfredo Covelli, and Jean-Yves Bonnefoy, while the Scientific Advisory Board (SAB) consists of Josep Tabernero, Roger Stupp, Enriqueta Felip, Aleix Prat, and Margaret Tempero. Recent news highlights include Peptomycs announcing a leadership transition to support growth, starting Phase 2 clinical trials for OMO-103 in advanced osteosarcoma patients, receiving Research IND Approval for an Innovative Window of Opportunity Trial with the OHSU Knight Cancer Institute, and collaboration with Barcelona's Premis Ciutat de Barcelona. |
| title | Peptomyc – Developing a Myc inhibitor to treat cancer |
| description | Peptomyc – Developing a Myc inhibitor to treat cancer |
| keywords | cancer, more, treatment, mini, cell, first, board, protein, phase, class, advisory, news, survival, resistance, therapeutic, patients, trial |
| upstreams | |
| downstreams | |
| nslookup | A 89.40.80.3 |
| created | 2025-11-11 |
| updated | 2025-11-25 |
| summarized | 2025-11-26 |
|
HIGHSPOTS | |
 tacticlinks.com | |
 whimed.com | |
 decoupled.ai | |
 3e9.me | |
 greenpeace.org | |
 escrache.org |
Traffic Boost by Tactic Links
[took: 458 ms]